Literature DB >> 20486197

Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality.

P Onguru1, S Dagdas, H Bodur, M Yilmaz, E Akinci, S Eren, G Ozet.   

Abstract

BACKGROUND: Crimean-Congo hemorrhagic fever (CCHF) is an acute illness affecting multiple organ systems and characterized by ecchymosis, visceral bleeding, and hepatic dysfunction. In this study, we aimed to investigate the profile of coagulopathy markers (platelet count, activated partial tromboplastin time (aPTT), prothrombin time (PT), international normalized ratio (INR), fibrinogen, protein C, protein S, antithrombin III, activated protein C resistance (APCR), and D-dimer) and their clinical significance in 83 CCHF-infected patients. SUBJECTS AND METHODS: We studied 83 CCHF patients who were admitted to Ankara Numune Education and Research Hospital during the spring and summer of2007. We compared the coagulopathy markers of fatal CCHF patients (n=9) with nonfatal cases (n=74).
RESULTS: Platelet count, PT, aPTT, INR, and fibrinogen were prognostic factors associated with mortality for CCHF. Especially, platelet count<20 x 10(9) cells/l and aPTT>60 sec were important. Protein C, protein S, APCR, and antithrombin III levels were not associated with mortality.
CONCLUSION: Laboratory tests including classical parameters (platelet count, PT, aPTT, INR, and fibrinogen) of coagulopathy seem to be enough for the followup of CCHF. Protein S, protein C, APCR, and D-dimer levels were not associated with mortality. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20486197      PMCID: PMC6647593          DOI: 10.1002/jcla.20383

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  17 in total

1.  Rapid and quantitative detection of Crimean-Congo hemorrhagic fever virus by one-step real-time reverse transcriptase-PCR.

Authors:  Mehmet Yapar; Hakan Aydogan; Alaaddin Pahsa; Bulent A Besirbellioglu; Hurrem Bodur; Ahmet C Basustaoglu; Cakir Guney; Ismail Y Avci; Kenan Sener; Mohammad H Abu Setteh; Ayhan Kubar
Journal:  Jpn J Infect Dis       Date:  2005-12       Impact factor: 1.362

2.  Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever.

Authors:  Mustafa Aydin Cevik; Ayşe Erbay; Hürrem Bodur; Selim Sirri Eren; Esragül Akinci; Kenan Sener; Pinar Ongürü; Ayhan Kubar
Journal:  Clin Infect Dis       Date:  2007-08-23       Impact factor: 9.079

3.  Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.

Authors:  C van 't Veer; K G Mann
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

Review 4.  Crimean-Congo hemorrhagic fever.

Authors:  Chris A Whitehouse
Journal:  Antiviral Res       Date:  2004-12       Impact factor: 5.970

5.  Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles.

Authors:  Thanh Hung Nguyen; Huan-Yao Lei; Trong Lan Nguyen; Yee-Shin Lin; Kao-Jean Huang; Bich Lien Le; Chiou-Feng Lin; Trai-Ming Yeh; Quang Ha Do; Thi Que Huong Vu; Lien-Cheng Chen; Jyh-Hsiung Huang; Thi My Lam; Ching-Chuan Liu; Scott B Halstead
Journal:  J Infect Dis       Date:  2004-01-09       Impact factor: 5.226

6.  Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality.

Authors:  Mustafa A Cevik; Ayse Erbay; Hürrem Bodur; Evrim Gülderen; Aliye Baştuğ; Ayhan Kubar; Esragül Akinci
Journal:  Int J Infect Dis       Date:  2007-12-11       Impact factor: 3.623

7.  Systemic host inflammatory and coagulation response in the Dengue virus primo-infection.

Authors:  María L Avila-Aguero; Claudio R Avila-Aguero; Suzane L Um; Alejandra Soriano-Fallas; Alejandro Cañas-Coto; S Betty Yan
Journal:  Cytokine       Date:  2004-09-21       Impact factor: 3.861

8.  The clinical pathology of Crimean-Congo hemorrhagic fever.

Authors:  R Swanepoel; D E Gill; A J Shepherd; P A Leman; J H Mynhardt; S Harvey
Journal:  Rev Infect Dis       Date:  1989 May-Jun

Review 9.  Activated protein C.

Authors:  J H Griffin; J A Fernández; A J Gale; L O Mosnier
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

10.  High serum levels of neopterin in patients with Crimean-Congo hemorrhagic fever and its relation with mortality.

Authors:  Pinar Onguru; Emin Ozgur Akgul; Esragul Akinci; Halil Yaman; Yasemin Gulcan Kurt; Ayse Erbay; Fatma Nurhayat Bayazit; Hurrem Bodur; Kemal Erbil; Cengiz Han Acikel; Mustafa Aydin Cevik
Journal:  J Infect       Date:  2008-05       Impact factor: 6.072

View more
  14 in total

1.  Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy.

Authors:  Marko Zivcec; David Safronetz; Dana Scott; Shelly Robertson; Hideki Ebihara; Heinz Feldmann
Journal:  J Infect Dis       Date:  2013-02-15       Impact factor: 5.226

2.  Can serum ferritin level predict disease severity in patients with crimean-congo hemorrhagic Fever?

Authors:  Maliheh Metanat; Batool Sharifi-Mood; Mehdi Tabatabaei; Mohammad Sarraf-Shirazi
Journal:  Eurasian J Med       Date:  2013-06

3.  Prognostic significance of antithrombin activity in patients with crimean-congo hemorrhagic Fever.

Authors:  Zulal Ozkurt; Kemalettin Ozden; Ilhami Kiki; Mustafa Usanmaz
Journal:  Eurasian J Med       Date:  2011-08

4.  A Syrian golden hamster model recapitulating ebola hemorrhagic fever.

Authors:  Hideki Ebihara; Marko Zivcec; Donald Gardner; Darryl Falzarano; Rachel LaCasse; Rebecca Rosenke; Dan Long; Elaine Haddock; Elizabeth Fischer; Yoshihiro Kawaoka; Heinz Feldmann
Journal:  J Infect Dis       Date:  2012-10-08       Impact factor: 5.226

5.  Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF).

Authors:  M Bakır; M G Gözel; I Köksal; Z Aşık; Ö Günal; H Yılmaz; A But; G Yılmaz; A Engin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-12       Impact factor: 3.267

6.  A cynomolgus macaque model for Crimean-Congo haemorrhagic fever.

Authors:  Elaine Haddock; Friederike Feldmann; David W Hawman; Marko Zivcec; Patrick W Hanley; Greg Saturday; Dana P Scott; Tina Thomas; Miša Korva; Tatjana Avšič-Županc; David Safronetz; Heinz Feldmann
Journal:  Nat Microbiol       Date:  2018-04-09       Impact factor: 17.745

7.  Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009.

Authors:  Nicholas G Conger; Kristopher M Paolino; Erik C Osborn; Janice M Rusnak; Stephan Günther; Jane Pool; Pierre E Rollin; Patrick F Allan; Jonas Schmidt-Chanasit; Toni Rieger; Mark G Kortepeter
Journal:  Emerg Infect Dis       Date:  2015-01       Impact factor: 6.883

Review 8.  Animal models of tick-borne hemorrhagic Fever viruses.

Authors:  Marko Zivcec; David Safronetz; Heinz Feldmann
Journal:  Pathogens       Date:  2013-05-28

9.  Thrombocytopenia as a predictor of severe acute kidney injury in patients with Hantaan virus infections.

Authors:  Meiliang Wang; Jiuping Wang; Tianping Wang; Jing Li; Ling Hui; Xiaoqin Ha
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

Review 10.  Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus.

Authors:  Marko Zivcec; Florine E M Scholte; Christina F Spiropoulou; Jessica R Spengler; Éric Bergeron
Journal:  Viruses       Date:  2016-04-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.